GUARDANT 360 (LIQUID BIOPSY)

Guardant360 is a comprehensive, non-invasive liquid biopsy test that analyzes circulating tumor DNA (ctDNA) from a blood sample to detect genomic alterations in cancer. It is widely used in precision oncology to guide targeted therapies, monitor treatment efficacy, and assess resistance mechanisms.

Available via

Home Collection, Lab Visit

Contains

1 parameters

Earliest reports in

18 Working Days

Test details
Preparations

No special preparations needed

Test included
GUARDANT 360 (LIQUID BIOPSY) includes 1 parameter

  • Guardant360 (liquid Biopsy)

Test code

G596

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Streck TubeStreck Tube20 ML

Specimen stability information

Streck Tube

Specimen rejection criteria

Test run frequency

Every Day TIME - 07:00

Turn around time

18 Working Days

Performing locations

Department

  • Advanced Molecular Diagnostics R&d

CPT and Loinc codes

GUARDANT 360 (LIQUID BIOPSY)

280000